AbCellera Biologics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.11.24	AbCellera to Present at Upcoming Investor Conferences in December and January (Businesswire)
05.11.24	AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript (MotleyFool)
04.11.24	AbCellera Reports Q3 2024 Business Results (Businesswire)
03.11.24	Ausblick: AbCellera Biologics zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
22.10.24	AbCellera to Present at Upcoming Investor Conferences in November 2024 (Businesswire)
04.10.24	AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 (Businesswire)
26.09.24	AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 (Businesswire)
29.08.24	AbCellera to Present at Upcoming Investor Conferences in September (Businesswire)
07.08.24	AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript (MotleyFool)
06.08.24	AbCellera Reports Q2 2024 Business Results (Businesswire)
05.08.24	Ausblick: AbCellera Biologics mit Zahlen zum abgelaufenen Quartal (finanzen.net)
31.07.24	AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines (Businesswire)
22.07.24	Erste Schätzungen: AbCellera Biologics stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
25.06.24	AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 (Businesswire)
13.06.24	Down 57%, Is AbCellera Biologics a Buy on the Dip? (MotleyFool)
28.05.24	AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 (Businesswire)
08.05.24	AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript (MotleyFool)
07.05.24	AbCellera Reports Q1 2024 Business Results (Businesswire)
06.05.24	Ausblick: AbCellera Biologics legt Zahlen zum jüngsten Quartal vor (finanzen.net)
01.05.24	AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies (Businesswire)
22.04.24	Erste Schätzungen: AbCellera Biologics zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
08.04.24	AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 (Businesswire)
03.04.24	AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 (Businesswire)
21.02.24	AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript (MotleyFool)
20.02.24	Recap: AbCellera Biologics Q4 Earnings (Benzinga)
05.12.23	: KeyBanc initiates coverage of AbCellera Biologics with an overweight rating as part of new coverage of digital biotech drug discovery sector (MarketWatch)
16.11.23	AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023 (Businesswire)
03.11.23	AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023 (Businesswire)
02.11.23	AbCellera Reports Q3 2023 Business Results (Businesswire)
01.11.23	Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology (Businesswire)
01.11.23	Ausblick: AbCellera Biologics mit Zahlen zum abgelaufenen Quartal (finanzen.net)
31.10.23	AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023 (Businesswire)
18.10.23	Erste Schätzungen: AbCellera Biologics legt Quartalsergebnis vor (finanzen.net)
11.10.23	AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023 (Businesswire)
27.09.23	AbCellera Announces Two T-Cell Engager Presentations at SITC 2023 (Businesswire)
20.09.23	AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron (Businesswire)
13.09.23	AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology (Businesswire)
02.08.23	Ausblick: AbCellera Biologics präsentiert Quartalsergebnisse (finanzen.net)
24.07.23	AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing (Businesswire)
19.07.23	Erste Schätzungen: AbCellera Biologics zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
06.07.23	AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023 (Businesswire)
29.05.23	AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023 (Businesswire)
24.05.23	AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu AbCellera Biologics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten